Healthcare -
Biotechnology - NASDAQ - US
$ 36.17
20.2 %
$ 5.63 B
Market Cap
-361.7
P/E
Price Target
Average
14.28%
Revenue Forecast
Estimate
75.21%
EBIT
Estimate
--264.41%
Net Income
Estimate
251.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
TG Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TGTX of $41.3 , with forecasts ranging from
a
low of
$20 to a high of $55 .
TGTX Lowest Price Target
Wall Street Target
20 USD
-44.71%
TGTX Average Price Target
Wall Street Target
41.3 USD
14.28%
TGTX Highest Price Target
Wall Street Target
55 USD
52.06%
REVENUE FORECAST
Revenue Forecast Chart TGTX
EBIT FORECAST
EBIT Forecast Chart TGTX
NET INCOME FORECAST
Net Income Chart TGTX